In AMD, low-grade chronic inflammation begins early with elevated IL-1β and IL-6 secreted by activated RPE and microglia, followed by progressive accumulation of VEGF in the intermediate to late stages, driving choroidal neovascularization and fibrosis [1,3,5,6]. Here, IL6 is linked to age-related macular degeneration.